Who is sponsoring NCT03276897?

NCT03276897 is sponsored by Derming SRL.

What drugs are being tested in NCT03276897?

Interventions in NCT03276897: Nutriage SPF 30 day cream and Nutriage night cream (Difa Cooper S.p.a, Italy).

What condition does NCT03276897 study?

NCT03276897 studies Face Aging/Photo Aging of Moderate Grade.

Is NCT03276897 still recruiting?

NCT03276897 is currently completed. Last updated 8 September 2017.

Last reviewed 2017-09-08 · How we verify

NCT03276897

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Efficacy and Tolerance Evaluation of a "Revitalizing" Face Treatment

Completed NA Last updated 8 September 2017

What this trial tests

NA trial testing Nutriage SPF 30 day cream and Nutriage night cream (Difa Cooper S.p.a, Italy) in Face Aging/Photo Aging of Moderate Grade in 22 participants. Completed in 30 June 2017.

Timeline

21 March 2017

Primary endpoint
30 June 2017

30 June 2017

Quick facts

Lead sponsor	Derming SRL
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	22
Start date	21 March 2017
Primary completion	30 June 2017
Estimated completion	30 June 2017
Sites	1 location across Italy

Drugs / interventions tested

Nutriage SPF 30 day cream and Nutriage night cream (Difa Cooper S.p.a, Italy)

Conditions studied

Face Aging/Photo Aging of Moderate Grade — all drugs for Face Aging/Photo Aging of Moderate Grade →

Sponsor

Derming SRL — full company profile →

Who can join

Adults 35 to 60, female only, with Face Aging/Photo Aging of Moderate Grade. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Efficacy and Tolerance Evaluation of a"revitalizing" face treatment consisting of a day and a night cream

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Antiaging efficacy of melatonin-based day and night creams: a randomized, split-face, assessor-blinded proof-of-concept trial.
Milani M, Sparavigna A. · · 2018 · cited 37× · PMID 29416368 · DOI 10.2147/ccid.s153905

Verify or expand the search:

Other Derming SRL trials

Trials by the same sponsor.

NCT04239768 — Efficacy of an Antiage Aesthetic Treatment for the Middle and Inferior Third of the Face · NA · completed
NCT04113265 — Aesthetic Performance of an Injective Treatment for the Inner Thighs, Knees and Arms · NA · completed
NCT04002856 — Aesthetic Performance of "Profhilo®" Injective Intradermal Treatment for the Neck · NA · completed
NCT03881189 — Efficacy and Tolerance Evaluation of an Injective Treatment for the Area Around the Eyes · NA · completed
NCT03801343 — Efficacy and Tolerance Evaluation of an Amino Acid Food Supplement · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03276897 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Derming SRL
Last refreshed: 8 September 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03276897.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing